← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2005Last known activity
Nov 10, 2024
Acquired by Biovail → Bausch Health Companies on Jan 1, 2009
Timeline
2000s
- Jan 1, 2004
Santhera— Founded
- Jan 1, 2004
Graffinity AG— Acquired
- Jan 1, 2004
Myocontract AG— Acquired
- Jan 1, 2009
Biovail— Acquired By
- Aug 17, 2009
Juvantia Pharma Ltd— Acquired
2010s
- Jan 1, 2010
Drugs by trial phase (8 distinct, 26 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 1 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Acidosis, Lactic
- Ataxia
- Atrophy
- Brain Diseases
- Cerebellar Ataxia
- Cystic Fibrosis
- Fibrosis
- Friedreich Ataxia
- Hypotension
- Hypotension, Orthostatic
- MELAS Syndrome
- Multiple System Atrophy
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Optic Atrophy, Hereditary, Leber
- Optic Nerve Diseases
- Parkinson Disease
- Peripheral Nervous System Diseases
- Shy-Drager Syndrome
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (26)
- NCT03433807Lead sponsorN/A—
- NCT04381091Lead sponsorN/A—
- NCT06713135Lead sponsorPhase 4Nov 10, 2024
- NCT06689527Lead sponsorPhase 1Aug 13, 2024
- NCT06649409Lead sponsorPhase 1Jun 17, 2024
- NCT05166109CollaboratorPhase 2Mar 31, 2022
- NCT05185622CollaboratorPhase 2Mar 21, 2022
- NCT03748199Lead sponsorPhase 1/Phase 2Nov 8, 2018
- NCT03603288Lead sponsorPhase 3Jul 4, 2018
- NCT02887443Lead sponsorPhase 1Sep 1, 2016
- NCT02814019Lead sponsorPhase 3Sep 1, 2016
- NCT02774005Lead sponsorPhase 4May 1, 2016
- NCT01805024Lead sponsorPhase 1Dec 1, 2014
- NCT01495715Lead sponsorPhase 3Dec 16, 2011
- NCT01303406Lead sponsorPhase 3Apr 1, 2011
Details
- Founded
- Liestal, CH Jan 1, 2004
- Last known activity
- Nov 10, 2024